BIIB Earnings Biogen
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | 2.15 | 2026-04-29 | 10-Q |
| FY 2025 | 2025-12-31 | 8.79 | 2026-02-06 | 10-K |
| Q3 2025 | 2025-09-30 | 9.14 | 2025-10-30 | 10-Q |
| Q2 2025 | 2025-06-30 | 5.97 | 2025-07-31 | 10-Q |
| Q1 2026 | 2025-03-31 | 1.64 | 2026-04-29 | 10-Q |
| FY 2025 | 2024-12-31 | 11.18 | 2026-02-06 | 10-K |
| Q3 2025 | 2024-09-30 | 9.35 | 2025-10-30 | 10-Q |
| Q2 2025 | 2024-06-30 | 6.70 | 2025-07-31 | 10-Q |
| Q1 2025 | 2024-03-31 | 2.70 | 2025-05-01 | 10-Q |
| FY 2025 | 2023-12-31 | 7.97 | 2026-02-06 | 10-K |
| Q3 2024 | 2023-09-30 | 6.26 | 2024-10-30 | 10-Q |
| Q2 2024 | 2023-06-30 | 6.74 | 2024-08-01 | 10-Q |
| Q1 2024 | 2023-03-31 | 2.67 | 2024-04-24 | 10-Q |
| FY 2024 | 2022-12-31 | 20.87 | 2025-02-12 | 10-K |
| Q3 2023 | 2022-09-30 | 17.07 | 2023-11-08 | 10-Q |
| Q2 2023 | 2022-06-30 | 9.27 | 2023-07-25 | 10-Q |
| Q1 2023 | 2022-03-31 | 2.06 | 2023-04-25 | 10-Q |
| FY 2023 | 2021-12-31 | 10.40 | 2024-02-14 | 10-K |
| Q3 2022 | 2021-09-30 | 7.90 | 2022-10-25 | 10-Q |
| Q1 2022 | 2021-06-30 | 5.68 | 2022-07-20 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.